177 related articles for article (PubMed ID: 16701525)
1. Antimicrobial susceptibilities of Bacteroides fragilis and Bacteroides thetaiotaomicron strains isolated from clinical specimens and human intestinal microbiota.
Ulger Toprak N; Celik C; Cakici O; Soyletir G
Anaerobe; 2004 Oct; 10(5):255-9. PubMed ID: 16701525
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of antimicrobial resistance patterns of enterotoxin gene positive and negative Bacteroides fragilis isolates].
Toprak NU; Yağci A; Celik C; Cakici O; Söyletir G
Mikrobiyol Bul; 2005 Apr; 39(2):145-52. PubMed ID: 16128024
[TBL] [Abstract][Full Text] [Related]
3. [Identification of anaerobic bacteria isolated from various clinical specimens and determination of antibiotic susceptibilities].
Doğan M; Baysal B
Mikrobiyol Bul; 2010 Apr; 44(2):211-9. PubMed ID: 20549955
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of tigecycline against Bacteroides species.
Betriu C; Culebras E; Gómez M; Rodríguez-Avial I; Picazo JJ
J Antimicrob Chemother; 2005 Aug; 56(2):349-52. PubMed ID: 15951353
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility trends of Bacteroides fragilis group isolates from Buenos Aires, Argentina.
Fernández Canigia L; Castello L; Di Martino A; Greco G; Legaria MC; Litterio M; Predari SC; Rollet R; Rossetti A; Carloni G; Sarchi MI; Bianchini H
Rev Argent Microbiol; 2007; 39(3):156-60. PubMed ID: 17987852
[TBL] [Abstract][Full Text] [Related]
6. [ESBL-positive strains of the Bacteroides fragilis group isolated from patients at the regional hospital center in Płock (Poland)].
Rokosz A; Pawłowska J; Sawicka-Grzelak A; Luczak M
Med Dosw Mikrobiol; 2004; 56(3):245-53. PubMed ID: 15773501
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility trending of blood isolates of the Bacteroides fragilis group over a 12-year period to clindamycin, ampicillin-sulbactam, cefoxitin, imipenem, and metronidazole.
Aldridge KE; Sanders CV
Anaerobe; 2002 Dec; 8(6):301-5. PubMed ID: 16887673
[TBL] [Abstract][Full Text] [Related]
8. [Bacteroides fragilis group in non-diarrheal human feces and its antimicrobial susceptibility].
Rodríguez E; Gamboa MM; Rodríguez C; Vargas P
Rev Esp Quimioter; 2006 Dec; 19(4):357-62. PubMed ID: 17235405
[TBL] [Abstract][Full Text] [Related]
9. National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004.
Snydman DR; Jacobus NV; McDermott LA; Ruthazer R; Golan Y; Goldstein EJ; Finegold SM; Harrell LJ; Hecht DW; Jenkins SG; Pierson C; Venezia R; Yu V; Rihs J; Gorbach SL
Antimicrob Agents Chemother; 2007 May; 51(5):1649-55. PubMed ID: 17283189
[TBL] [Abstract][Full Text] [Related]
10. Resistance trends of Bacteroides fragilis group over an 8-year period, 1997-2004, in Korea.
Roh KH; Kim S; Kim CK; Yum JH; Kim MS; Yong D; Lee K; Kim JM; Chong Y
Korean J Lab Med; 2009 Aug; 29(4):293-8. PubMed ID: 19726890
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility of anaerobic bacteria from the intestinal microflora of healthy children and antimicrobial-treated children in Nicaragua.
Cáceres M; Carera E; Palmgren AC; Nord CE
Rev Esp Quimioter; 1998 Sep; 11(3):221-8. PubMed ID: 9795308
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial susceptibility of clinical isolates of Bacteroides fragilis group organisms recovered from 2009 to 2012 in a Korean hospital.
Yim J; Lee Y; Kim M; Seo YH; Kim WH; Yong D; Jeong SH; Lee K; Chong Y
Ann Lab Med; 2015 Jan; 35(1):94-8. PubMed ID: 25553287
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic resistance among anaerobic Gram-negative bacilli: lessons from a French multicentric survey.
Behra-Miellet J; Calvet L; Mory F; Muller C; Chomarat M; Bézian MC; Bland S; Juvenin ME; Fosse T; Goldstein F; Jaulhac B; Dubreuil L
Anaerobe; 2003 Jun; 9(3):105-11. PubMed ID: 16887696
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility of anaerobic bacteria in Bulgaria.
Marina M; Ivanova M; Kantardjiev T
Anaerobe; 2009 Aug; 15(4):127-32. PubMed ID: 19292999
[TBL] [Abstract][Full Text] [Related]
15. Do antimicrobial susceptibility patterns of colonic isolates of Bacteroides species change after antibiotic prophylaxis with cefoxitine during elective abdominal surgery?
Toprak NU; Güllüoğlu BM; Cakici O; Akin ML; Demirkalem P; Celenk T; Söyletir G
World J Surg; 2005 Oct; 29(10):1311-5. PubMed ID: 16142428
[TBL] [Abstract][Full Text] [Related]
16. Inducible metronidazole resistance in nim-positive and nim-negative bacteroides fragilis group strains after several passages metronidazole containing columbia agar plates.
Schaumann R; Petzold S; Fille M; Rodloff AC
Infection; 2005 Oct; 33(5-6):368-72. PubMed ID: 16258869
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of 11 antibiotics against 74 anaerobes isolated from pediatric intra-abdominal infections.
Goldstein EJ; Citron DM; Vaidya SA; Warren YA; Tyrrell KL; Vreni Merriam C; Fernandez H
Anaerobe; 2006 Apr; 12(2):63-6. PubMed ID: 16701615
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the post-antibiotic effect (PAE) induced by ceftizoxime, ceftriaxone, cefoxitin, ampicillin-sulbactam, and ticarcillin-clavulanate against selected isolates of Bacteroides fragilis and B. thetaiotaomicron.
Aldridge KE
Anaerobe; 2002 Dec; 8(6):295-9. PubMed ID: 16887672
[TBL] [Abstract][Full Text] [Related]
19. Determinants of resistance in Bacteroides fragilis strains according to recent Brazilian profiles of antimicrobial susceptibility.
Paula GR; Falcão LS; Antunes EN; Avelar KE; Reis FN; Maluhy MA; Ferreira MC; Domingues RM
Int J Antimicrob Agents; 2004 Jul; 24(1):53-8. PubMed ID: 15225862
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial susceptibility of Bacteroides fragilis group organisms in Hong Kong by the tentative EUCAST disc diffusion method.
Ho PL; Yau CY; Ho LY; Lai EL; Liu MC; Tse CW; Chow KH
Anaerobe; 2017 Oct; 47():51-56. PubMed ID: 28414107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
